GLP-RT Injectable Peptide 10mg

$140.00

Out of stock

Free worldwide shipping on all orders over $50

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

BPC-157 Injection Vial - Primal Peptides
GLP-RT Injectable Peptide 10mg
$140.00

GLP-RT (Retatrutide) – Research Peptide for Multi-Pathway Metabolic and Weight Regulation Studies


Product Usage: All products made available on this website are intended exclusively for research and development purposes and are strictly not for human consumption or therapeutic use. These products are not approved by the U.S. Food and Drug Administration (FDA), and no statements on this website have been evaluated by the FDA. The products and any information provided are not intended to diagnose, treat, cure, or prevent any disease or medical condition.

Our research-grade GLP-RT (Retatrutide) is a novel multi-agonist peptide currently under investigation for its broad metabolic and weight-regulation potential. Retatrutide is a triple agonist targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors, making it a promising candidate for studies in obesity, glucose control, insulin resistance, and energy expenditure.

Potential Research Benefits:

  • Multi-Pathway Metabolic Activation: Combines GLP-1, GIP, and glucagon receptor agonism to support appetite regulation, fat loss, and improved energy balance in metabolic models.
  • Weight Management Studies: Early research in preclinical and clinical models shows significant reductions in body weight and BMI with consistent administration.
  • Glucose and Insulin Sensitivity: Enhances glucose-dependent insulin secretion while reducing postprandial glucose spikes, relevant for type 2 diabetes and insulin resistance studies.
  • Increased Energy Expenditure: Glucagon receptor activation may promote lipolysis and increased resting metabolic rate.
  • Liver and Cardiovascular Biomarkers: Emerging studies explore potential downstream benefits in hepatic fat reduction and cardiometabolic health markers.

Clinical Research References:

  • Retatrutide is currently being investigated in clinical trials for obesity, type 2 diabetes, and related metabolic disorders due to its multi-receptor activation mechanism.

Storage and Handling:

  • Store at 2–8°C (35–46°F) in a refrigerated environment.
  • Protect from light and moisture.
  • After reconstitution with bacteriostatic water, store refrigerated and use within 4–6 weeks for maximum integrity.

Disclaimer:

This product is intended strictly for research purposes only. Not for human consumption or therapeutic use. Researchers are responsible for ensuring compliance with applicable laws and regulations.

Reviews

There are no reviews yet.

Be the first to review “GLP-RT Injectable Peptide 10mg”

Your email address will not be published. Required fields are marked *